SlideShare a Scribd company logo
1 of 48
HOSPICE ELIGIBILITY AND
RECERTIFICATION
TERRI HANLON M.D.
MEDICAL DIRECTOR
CREEKSIDE HOSPICE
Objectives
 Identify eligible patients early
 Knowledge of LCDs
 Prognosis prediction
 The “new old rules” regarding debility
Prognostic Accuracy
 Initial certification based on physician or medical
director’s best clinical judgment regarding the usual
predicted course of the disease
 “Individuals who present in the same way generally die
in 6 months.”
 Several studies have indicated about an 85% accuracy in
physician’s 6 month prognosis
Eligibility Perspectives
 Medicare Language: “ 6 months prognosis or less”
 Medicare Reimbursement: “about 5 months”
 Physicians: “Are they going to die tonight”
 Hospice Nurse: “Do they NEED us?”
 Marketer: “I am pretty sure I heard them cough”
Eligibility Myths
 Eligibility vs. Compassion
 Eligibility vs. Care needed or provided
 Physician referral vs. other
 Cancer = Eligibility
Local Coverage Determinations
LCD’s
 1995, LMRP devised by NHO as “general guidelines”
 LCD’s might not be up to date
 Different states may have different fiscal
intermediaries, so LCD’s may not be uniform
 Limited Prognosis is the only real eligibility criterion.
Some patients may not meet the criteria but still be
appropriate
Patient Must Meet 1 of 4 Criteria
(to guarantee Medicare payment)
 Meets all LCD criteria
 Meets most of LCD criteria and has a documented rapid
clinical decline
 Meets most of LCD criteria and has significant
comorbities
 A documented provider’s clinical assessment of limited
prognosis
General Guidelines for all
Diagnosis (Nondisease Specific)
• Clinical progression of disease
• Performance, functional status
• Cognition
• Nutritional status
• Severity of comorbitidites
• Burden of symptoms
Documenting Clinical Decline
 OBTAIN AND REVIEW OLD RECORDS
 Get names of all of patients physicians and hospitals
 Serial physical findings and diagnostic studies
 Multiple recent hospitalizations, ED visits or office visits
 Changes in the MDS for nursing facilities
 Deterioration while receiving home health services
 Failure at rehabilitation
DISEASE PROGRESSION
Clinical Status
Symptoms
Signs
Laboratory
Clinical Status
 Recurrent or intractable infections such as pneumonia,
sepsis or upper urinary tract
 Progressive inanition as documented by:
 Weight loss and decreasing anthropomorphic measurements
not due to *reversible causes such as depression or diuretics
 Dysphagia leading to recurrent aspiration and/or
inadequate oral intake documented by decreased
portions eaten
 Progressive stages 3-4 pressure ulcers in spite of optimal
treatment
Symptoms
 Dyspnea, tachypnea
 Cough, intractable
 Nausea/vomiting poorly responsive to treatment
 Diarrhea, intractable
 Pain, persistant, requiring increasing doses of
medication
Signs
 Systolic BP <90 or progressive postural hypotension
 Ascites
 Venous, arterial or lymphatic obstruction
 Edema
 Pleural/pericardial effusion
 Weakness
 Changes in level of consciousness
Laboratory
 Incr. pCO2, decr. pO2, or decr SaO2
 Incr. calcium, BUN/Cr or LFTs
 Increasing tumor markers (CEA, PSA)
 Abnormal electrolytes, Na+ or K+
Nutrition
 10% weight loss in the elderly over ~6mo
 BMI <22kg/m2 (BMI=703x (wt in lbs)/(ht in inches)2
 Anthropomorphic measures
 Arm, thigh and abdominal girth
 Low serum albumin <2.5
 Declines enteral or parenteral nutritional support
Function
 Serial evaluations of ADL’s: bathing, dressing, feeding,
transfers, toileting, ambulation
 IADL’s
 ADL deficits are the most important predictor of 6 mo.
Mortality (at least 3/6)
 KPS 50%, PPS 40%
 Active symptoms
Comorbidities
 Documenting other significant existing diseases
 Document the severity and progression of these diseases
 Supporting evidence for 6 mo prognosis:
 Additional organ systems involved
 Diseases that affect prognosis
 Severity more important than the amount of comorbidities
Comorbid Conditions
 COPD
 CHF
 CAD
 DM
 Neurologic disease
(CVA, ALS, MS,
Parkinson’s)
 Dementia
 Sepsis
 Liver disease
 AIDS
Is “Debility” a hospice diagnosis?
 CMS expects that hospices not use ‘debility’ or ‘adult
failure to thrive’ as the primary diagnosis
 In those cases that clearly have another diagnosis that
can be considered as a principal diagnosis and as many
other diagnoses that are related or that contribute to
the patient’s terminality be included (up to 17
diagnoses may be submitted).
 CMS cites that the Medicare hospice benefit requires the
hospice to cover all palliative care related to the
terminal illness and all related or contributing illnesses
Cancer (simplified)
 KPS/PPS may be initially >50%
 Aggressive, recurrant or metastatic
 Unresponsive to or not a candidate for disease remitting
therapy
 Patient declines further therapy
 Certain cancers have poor prognosis
 SCLCA, brain CA, pancreatic cancer, malignant melanoma,
stage IV hepatobiliary and gallbladder CA, stage IV renal CA
Cancer
 Cancers with higher probability of cure
 Testicular, ALL, Hodgkin’s
 Cancers that may have more favorable extended
prognosis with palliative treatment even after
metastasis
 Prostate, breast, MDS, CML, CLL, multiple
myeloma
Non-Cancer Disease Specific
Criteria
 ALS
 Cardiac Disease
 CAD, CHF, Cardiomyopathy
 Pulmonary Disease
 COPD, Emphysema,
Intersitial lung disease
 Liver Disease
 Renal Disease
 HIV/AIDs
 Dementia
 Multi-infarct, Lewy Body,
NPH
 Stroke/Coma
 Parkinson’s Disease
Pulmonary Disease
1. **Severe chronic lung disease
 Disabling dyspnea at rest (unresponsive to bronchodilators)
 FEV1 < 30% predicted
 Recurrent respiratory infections and or RF
 Serial decrease of FEV1>40ml/yr
2. **Hypoxemia at rest on room air, pO2 <55mmHg, pCO2 >50%
or O2sat<88%. Patient on chronic O2
3. RHF secondary to Cor pulmonale
4. Unintentional progressive wt loss >10% in last 6 mo
5. Resting tachycardia > 100/min
Pulmonary Disease-Assessment
 H/o VDRF
 pO2/pCO2, 50/50
 SaO2 <88% on room air
 Elderly
 <90% ideal body wt
 Continuous O2
 Bed-chair existence
 Cough and sputum
 Hypotension, BP 100/80
 Resting tachycardia >100
 Tachypnea
 Chest wall abnormalities
 Use of accessory respiratory
muscles
 Cyanosis, clubbing
 Edema
 Wheezing, decr. BrS
Heart Disease
1. Patient has had maximal medical management or is not a
surgical candidate
2. NYHA IV, significant symptoms at rest---CHF or angina
1. EF <20% or diasytolic disfunction
2. Inability to carry on any physical activity without pain/SOB
3. Supportive factors
1. Resistant symptomatic SVTs or ventricular arrythmias
2. H/o cardiac arrest or resuscitation
3. H/o unexplained syncope
4. Brain embolism of cardiac origin
5. HIV disease
Cardiac Assessment
 NYHA IV
 H/o cardiac arrest
 AICD/pacer
 H/o syncope
 Optimal management with
vasodilators or diuretics
 Orthopnea and PND
 Cachexia, fatique
 Continuous oxygen
 Hypotension
 Tachycardia
 “Gallop” S1/S2 + S3, S4
 Crackles
 Edema
 Cyanosis
 JVD
 Diaphoresis
Renal disease: ARF
Table 1
*Refusal or withdrawal of
dialysis
CrCl <10ml/min (<15ml/min
for DM),
CrCl <15ml/min (<20ml/min
for DM) with CHF
or Serum CrCl >8 (>6 for
DM)
 Mechanical ventillation
 Malignancy
 Chronic lung disease, advanced
cardiac disease or liver disease
 Sepsis
 Immunosuppression/AIDs
 Albumin <3.5
 Cachexia
 Plt <25,000
 DIC or GIB
Renal Disease: CRF
 Table 1 applies
 Signs of RF
 Oliguria <400ml/hr
 Hyperkalemia >7,
refractory
 Uremic pericarditis
 Hepatorenal syndrome
 Intractable fluid overload
 Cachexia
 Age > 75
 Symptoms of Uremia
 Confusion, obtundation
 Intractable N/V
 Pruritis
 Edema
Liver Disease
1. Abnormal labs
1. PT>5 sec over control,
INR>1.5
2. Serum albumin <2.5
2. Evidence of ESLD
1. Refractory ascites
2. SBP
3. HRS, oliguria <400ml/day
and urine Na+ <10mEq/l
4. Hepatic encephalopathy
5. Recurrent variceal
bleeding
 Supporting factors
 Malnutrition
 Muscles wasting, weakness
 Alcoholism >80gm
EtOH/day
 Hepatocellular CA
 HBsAg
 Hepatitis C refractory to
interferon tx
Assessment of ESLD
 Symptoms
 Chg LOC
 Sleep disturbance
 Depression
 Emotional lability
 Somnlence
 Obtundation
 Slurred speech
 Oliguria, anuria
 Signs
 Asterixis
 Palmar erythema
 Hepatomegaly
 Distended abdomen, fluid
wave
 Edema
 Spider hemangioma
 Jaundice, scleral icterus
 Stupor
 coma
Neurologic Disease
 Dementias
 CVA/Coma
 ALS/ motor neuron disease
Dementia
 FAST scale > 7
 Unable to ambulate without
assistance
 Unable to dress without
assistance
 Unable to bathe without
assistance
 Urinary and fecal incontinence
 No consistently meaningful
verbal communication:
stereotypical phrases or <6
intelligible words
 Patients should have had one of
the following in the past 12 mo
 Aspiration pneumonia
 Pyelonephritis
 Septicemia
 Decubitus ulcers, multiple stg3-
4
 Fever, recurrent after antibx
 10% wt loss over 6 mo
 Albumin <2.5
Acute Stroke and Coma
 Has at least one of the
following for 3 days:
 Coma
 PVS
 Obtundation/myoclonus
 Postanoxic stroke
 High risk mortality after 3
days
 Abnorm brainstem response
 Absent verbal response
 Absent withdrawal to pain
 Cr >1.5
 Supporting factors:
 Aspiration pneumonia
 Pyelonephritis
 Sepsis
 Refractory stage 3-4
decubitus ulcers
 Recurrant fever after
antibiotics
Poststroke or Multiinfarct Dementia
 Fast >7
 One of supporting conditions
(last slide) in 3-6 months
 Altered nutritional status
 Dysphagia
 Refusal to eat
 Impaired nutritional status
despite artificial nutrition
 Poor porgnostic Factors:
 Nontraumatic hemorrhagic
stroke
 Lg volume on CT
 Ventricular extension
 >30% cerebrum
 Midline shift>1.5cm
 Obstructive hydrocephalus
 Thrombo/embolic stroke
 Large ant. Infarcts
 Large bihemispheric infarcts
 Basilar artery occlusion
 Bilateral vertebral art.
occlusion
ALS and other Motor Neuron Disease
 Rapid Neurological Progression over 12 mo
 Loss of ambulation, speech, chewing
 Progressive dependence
 Critically Impaired Ventilatory Capacity
 VC < 30%
 Dyspnea at rest
 Refusal of ventillatory support
 Critical Nutritional Impairment
 Dysphagia or refusal to eat
**artificial nutrition or ventillation will significantly alter
prognosis
ALS and Motor Neuron Disease
 Examination by a neurologist within 3 months to confirm
diagnosis
 Supporting factors
 Aspiration pneumonia
 Pyelonephritis
 Septicemia
 Decubitus ulcers, multiple, stages III or IV
 Recurrant fever after antibx
HIV Disease
 CD4 < 25 cell/ mcl (w/o acute illness)
 HIV RNA viral load >100,000 persistant or
 HIV RNA viral load <100,000 plus:
 Refusal of antivirals or prophlactic meds
 Declining functional status, KPS < 50
 CNS lymphoma
 PML
 Cryptosporidiosis or toxoplasmosis
 AIDs wasting or AIDs dementia
 MAC bacteremia
 Visceral Kaposi’s sarcoma
 Renal failure
HIV disease
 Supporting Factors:
 Chronic persistant diarrhea > 1yr
 Alb <2.5
 Substance abuse
 Age >50
 Symptomatic CHF at rest
 Advanced liver disease
 Age > 50yrs
Common Errors
 Conclusions without objective evidence
 Disease without documented symptoms
 Conflicting documentation
 Failure to tract S/S over time 6-12 mo
 Not providing descriptive narratives
Burden of Illness
 Age at disease onset, years of illness
 Advanced age
 Degree of frailty
 Location/environment
 CG ability
 Access to healthcare providers
 Secondary conditions and comorbid conditions
Scales for Documentation
 Function: KPS, PPS, ECOG, ADLs, IADLs, Morse Fall scale
 Nutrition: ht, wt, BMI, meal %, cal estimates
 Mental Status: Ramsay sedation scale, FAST, MMSE
 Cardiac: NYHA, BNP, ECHO
 Respiratory: Functional dyspnea scale
 Skin: skin turgor, edema, capillary refill, braden scale,
pressure ulcer stages
 Symptoms: pain scale, PAINAD scale, response to tx
Certification
 Written or oral certification of terminal illness within 2
days after the beginning of the election period
 Must be signed by the hospice physician and the
patient’s attending physician
 Written certification must be obtained before the claim
is sent for payment
 If the patient is admitted in the 3rd benefit period or
beyond there must be a F2F encounter
Ineligibility
 Decision of IDG, attending and medical director
 Patient must be discharged when ineligibility is
determined, not end of cert period
 Improvement---sustained, nonmalignant diseases wax
and wane
 Remember, patients may get better
 Admit often occurs after an acute event
 Hospice care may improve symptoms
Case example #1
 Mr. Jones is a 72 y/o male with multiple medical
problems including chronic renal disease due to
diabetes. His GFR ranges from 18-22%. He has had a
fistula put in one year ago but is “holding off on dialysis
until his GFR hits 16% as the “bottom limit” to have to
do dialysis. He was referred to hospice by his HMO care
case manager who states that they have seen a decline
in his condition over the last year. He has had two
recent hospitalizations. They were both for CHF with
severe scrotal edema and dyspnea. He is also a chronic
alcoholic, drinking a tall glass of scotch and vermooth
every night. On arrival to the ipu he had been without
alcohol for nearly two days and appeared completely
lucid and conversant. However when he began drinking
 Case study (cont)
His usual nightly alcohol he became more confused and
agitated with repeated falls. His scrotal edema was
slow to resolve. The patient lives at home alone.
What other information would you like to find out?
His he hospice appropriate?
What would his hospice diagnosis be?
Can he still have dialysis?
Case example #2
 Yvonne is a 52 y/o female with a mild mental disability
due to cerebral palsy. She had multiple hospitalizations
over the past 6-12 months for altered mental status and
seizures. She was on multidrug therapy for what
appeared to be atypical chronic seizures. With these
episodes she also had recurrent episodes of aspiration
and pneumonia. Before the most recent hospitalization
she was able to get around by a wheel chair and was
taking care of her elderly mother. She failed a swallow
study and did appear to have difficulty swallowing. She
was also very depressed because her mother was unable
to take care of her at home. She became mostly
bedbound after the last hospitalization, dependent on
5/6 ADL’s with KPS 30%.
 Case Study (cont.)
Is this patient hospice eligible?
What further information do you want?
Hospice_Eligibility_for_Residents

More Related Content

What's hot

Hypertension in the Elderly
Hypertension in the ElderlyHypertension in the Elderly
Hypertension in the ElderlyMarc Evans Abat
 
hypertension and coronary artery disease
hypertension and coronary artery diseasehypertension and coronary artery disease
hypertension and coronary artery diseasemagdy elmasry
 
2017 AHA ACC Hypertension Guidelines made simple
2017 AHA ACC Hypertension Guidelines made simple2017 AHA ACC Hypertension Guidelines made simple
2017 AHA ACC Hypertension Guidelines made simpleMgfamiliar Net
 
JNC 8 guideline to Management of Hypertension
JNC 8 guideline to Management of HypertensionJNC 8 guideline to Management of Hypertension
JNC 8 guideline to Management of HypertensionPranav Sopory
 
Hypertension jnc 8 guideline(1)
Hypertension jnc 8 guideline(1)Hypertension jnc 8 guideline(1)
Hypertension jnc 8 guideline(1)Dr.Chandan Kumar
 
2017 ACC/AHA Hypertension guidelines
2017 ACC/AHA Hypertension guidelines 2017 ACC/AHA Hypertension guidelines
2017 ACC/AHA Hypertension guidelines Eugenio Santoro
 
Management of hypertension in elderly person.
Management of hypertension in elderly person.Management of hypertension in elderly person.
Management of hypertension in elderly person.Ramachandra Barik
 
Hypertension latest guidelines seminar(2017 ACC/AHA guidelines)
Hypertension latest guidelines seminar(2017 ACC/AHA guidelines)Hypertension latest guidelines seminar(2017 ACC/AHA guidelines)
Hypertension latest guidelines seminar(2017 ACC/AHA guidelines)Rahul Bhati
 
Nursing health assessment mnemonics & tips
Nursing health assessment mnemonics & tipsNursing health assessment mnemonics & tips
Nursing health assessment mnemonics & tipsMustafa Abdalla
 
Blood Pressure Targets  2017.Still Struggling for the Right Answer
Blood Pressure Targets  2017.Still Struggling for the Right AnswerBlood Pressure Targets  2017.Still Struggling for the Right Answer
Blood Pressure Targets  2017.Still Struggling for the Right Answermagdy elmasry
 
Bp targets 2014-2015
Bp targets 2014-2015Bp targets 2014-2015
Bp targets 2014-2015magdy elmasry
 

What's hot (20)

Hipertensión Arterial 2014: De las Guías a la Práctica Clínica - Dr. José R. ...
Hipertensión Arterial 2014: De las Guías a la Práctica Clínica - Dr. José R. ...Hipertensión Arterial 2014: De las Guías a la Práctica Clínica - Dr. José R. ...
Hipertensión Arterial 2014: De las Guías a la Práctica Clínica - Dr. José R. ...
 
2017 hypertension guidelines
2017 hypertension guidelines 2017 hypertension guidelines
2017 hypertension guidelines
 
Hypertension in the Elderly
Hypertension in the ElderlyHypertension in the Elderly
Hypertension in the Elderly
 
Htn 2017 jama
Htn 2017 jamaHtn 2017 jama
Htn 2017 jama
 
hypertension and coronary artery disease
hypertension and coronary artery diseasehypertension and coronary artery disease
hypertension and coronary artery disease
 
Jnc 8
Jnc 8Jnc 8
Jnc 8
 
Hypertension+current
Hypertension+currentHypertension+current
Hypertension+current
 
2017 AHA ACC Hypertension Guidelines made simple
2017 AHA ACC Hypertension Guidelines made simple2017 AHA ACC Hypertension Guidelines made simple
2017 AHA ACC Hypertension Guidelines made simple
 
Jnc 8
Jnc 8Jnc 8
Jnc 8
 
JNC 8 guideline to Management of Hypertension
JNC 8 guideline to Management of HypertensionJNC 8 guideline to Management of Hypertension
JNC 8 guideline to Management of Hypertension
 
Hypertension jnc 8 guideline(1)
Hypertension jnc 8 guideline(1)Hypertension jnc 8 guideline(1)
Hypertension jnc 8 guideline(1)
 
2017 ACC/AHA Hypertension guidelines
2017 ACC/AHA Hypertension guidelines 2017 ACC/AHA Hypertension guidelines
2017 ACC/AHA Hypertension guidelines
 
Nursing mnemonics tips
Nursing mnemonics tipsNursing mnemonics tips
Nursing mnemonics tips
 
Hipertensinarterial jnc 8
Hipertensinarterial jnc 8Hipertensinarterial jnc 8
Hipertensinarterial jnc 8
 
Management of hypertension in elderly person.
Management of hypertension in elderly person.Management of hypertension in elderly person.
Management of hypertension in elderly person.
 
Hypertension latest guidelines seminar(2017 ACC/AHA guidelines)
Hypertension latest guidelines seminar(2017 ACC/AHA guidelines)Hypertension latest guidelines seminar(2017 ACC/AHA guidelines)
Hypertension latest guidelines seminar(2017 ACC/AHA guidelines)
 
Nursing health assessment mnemonics & tips
Nursing health assessment mnemonics & tipsNursing health assessment mnemonics & tips
Nursing health assessment mnemonics & tips
 
Blood Pressure Targets  2017.Still Struggling for the Right Answer
Blood Pressure Targets  2017.Still Struggling for the Right AnswerBlood Pressure Targets  2017.Still Struggling for the Right Answer
Blood Pressure Targets  2017.Still Struggling for the Right Answer
 
Bp targets 2014-2015
Bp targets 2014-2015Bp targets 2014-2015
Bp targets 2014-2015
 
Hypertension
HypertensionHypertension
Hypertension
 

Viewers also liked

Viewers also liked (16)

Medical Director Responsibilities and Hospice Eligibility and Recertification
Medical Director Responsibilities and Hospice Eligibility and RecertificationMedical Director Responsibilities and Hospice Eligibility and Recertification
Medical Director Responsibilities and Hospice Eligibility and Recertification
 
PHILIP LOFTUS updated
PHILIP LOFTUS updatedPHILIP LOFTUS updated
PHILIP LOFTUS updated
 
SMC - Minisite/Landing Pages
SMC - Minisite/Landing PagesSMC - Minisite/Landing Pages
SMC - Minisite/Landing Pages
 
Newsletter 11 March 2015
Newsletter 11 March 2015Newsletter 11 March 2015
Newsletter 11 March 2015
 
Test Presentation
Test PresentationTest Presentation
Test Presentation
 
Missione 96
Missione 96Missione 96
Missione 96
 
Wolfenstein Review
Wolfenstein ReviewWolfenstein Review
Wolfenstein Review
 
Retorik svenska 1
Retorik svenska 1Retorik svenska 1
Retorik svenska 1
 
Newsletter 15 apr 2015
Newsletter 15 apr 2015Newsletter 15 apr 2015
Newsletter 15 apr 2015
 
Escuelas Administrativas
Escuelas Administrativas Escuelas Administrativas
Escuelas Administrativas
 
Mini sites ml 20160225
Mini sites ml 20160225Mini sites ml 20160225
Mini sites ml 20160225
 
Files15 file2289
Files15 file2289Files15 file2289
Files15 file2289
 
Christmas Catalogue
Christmas CatalogueChristmas Catalogue
Christmas Catalogue
 
Saravanan rajalingam
Saravanan rajalingamSaravanan rajalingam
Saravanan rajalingam
 
Travel Guide: 24 hours in Paris
Travel Guide: 24 hours in ParisTravel Guide: 24 hours in Paris
Travel Guide: 24 hours in Paris
 
CERTIFICATES
CERTIFICATESCERTIFICATES
CERTIFICATES
 

Similar to Hospice_Eligibility_for_Residents

Heart failure in children
Heart failure in childrenHeart failure in children
Heart failure in childrenLWCH, UAE
 
Day 2 senior healthcare consultant conference
Day 2 senior healthcare consultant conferenceDay 2 senior healthcare consultant conference
Day 2 senior healthcare consultant conferencenomadicnurse
 
Sickle cell disease sandip
Sickle cell disease sandipSickle cell disease sandip
Sickle cell disease sandipSandip Gupta
 
Antiphospholipid antibody syndrome
Antiphospholipid antibody syndromeAntiphospholipid antibody syndrome
Antiphospholipid antibody syndromeDimi Laloo
 
Oncological Emergencies comep OCT 2010
Oncological Emergencies  comep OCT  2010Oncological Emergencies  comep OCT  2010
Oncological Emergencies comep OCT 2010NES
 
MON 2011 - Slide 33 - A. Hoy - Advanced disease management
MON 2011 - Slide 33 - A. Hoy - Advanced disease managementMON 2011 - Slide 33 - A. Hoy - Advanced disease management
MON 2011 - Slide 33 - A. Hoy - Advanced disease managementEuropean School of Oncology
 
MCO 2011 - Slide 37 - A. Hoy - Advanced disease management
MCO 2011 - Slide 37 - A. Hoy - Advanced disease managementMCO 2011 - Slide 37 - A. Hoy - Advanced disease management
MCO 2011 - Slide 37 - A. Hoy - Advanced disease managementEuropean School of Oncology
 
ANESTHESIA PREOPERATIVE EVALUATION.pptx
ANESTHESIA PREOPERATIVE EVALUATION.pptxANESTHESIA PREOPERATIVE EVALUATION.pptx
ANESTHESIA PREOPERATIVE EVALUATION.pptxKristelQuintasQuital1
 
Hypertensive crisis in children copy copy.pptx
Hypertensive crisis in children  copy copy.pptxHypertensive crisis in children  copy copy.pptx
Hypertensive crisis in children copy copy.pptxAltaf Bhat
 
Geriatric Population. Geriatric Palliative and End-of-Life Care.
Geriatric Population. Geriatric Palliative and End-of-Life Care.Geriatric Population. Geriatric Palliative and End-of-Life Care.
Geriatric Population. Geriatric Palliative and End-of-Life Care.Michelle Peck
 
10. Pulmonary Embolism.pptx
10. Pulmonary Embolism.pptx10. Pulmonary Embolism.pptx
10. Pulmonary Embolism.pptxAnuragChapagain4
 
Major Case Presentation Final Version
Major Case Presentation Final VersionMajor Case Presentation Final Version
Major Case Presentation Final VersionMmorshed217
 
A Formal Patient Presentation
A Formal Patient PresentationA Formal Patient Presentation
A Formal Patient PresentationMadison Block
 
Hyperviscosity syndrome CPC
 Hyperviscosity syndrome CPC Hyperviscosity syndrome CPC
Hyperviscosity syndrome CPCNaseer Nazeer
 
Bronchial embolisation to treat bleeding caused by chronic pulmonary aspergil...
Bronchial embolisation to treat bleeding caused by chronic pulmonary aspergil...Bronchial embolisation to treat bleeding caused by chronic pulmonary aspergil...
Bronchial embolisation to treat bleeding caused by chronic pulmonary aspergil...Graham Atherton
 

Similar to Hospice_Eligibility_for_Residents (20)

Heart failure in children
Heart failure in childrenHeart failure in children
Heart failure in children
 
Day 2 senior healthcare consultant conference
Day 2 senior healthcare consultant conferenceDay 2 senior healthcare consultant conference
Day 2 senior healthcare consultant conference
 
AHF In Critical Illness
AHF In Critical IllnessAHF In Critical Illness
AHF In Critical Illness
 
Sickle cell disease sandip
Sickle cell disease sandipSickle cell disease sandip
Sickle cell disease sandip
 
Antiphospholipid antibody syndrome
Antiphospholipid antibody syndromeAntiphospholipid antibody syndrome
Antiphospholipid antibody syndrome
 
Heart Failure[1][2]
Heart Failure[1][2]Heart Failure[1][2]
Heart Failure[1][2]
 
Hypertension
HypertensionHypertension
Hypertension
 
Oncological Emergencies comep OCT 2010
Oncological Emergencies  comep OCT  2010Oncological Emergencies  comep OCT  2010
Oncological Emergencies comep OCT 2010
 
MON 2011 - Slide 33 - A. Hoy - Advanced disease management
MON 2011 - Slide 33 - A. Hoy - Advanced disease managementMON 2011 - Slide 33 - A. Hoy - Advanced disease management
MON 2011 - Slide 33 - A. Hoy - Advanced disease management
 
MCO 2011 - Slide 37 - A. Hoy - Advanced disease management
MCO 2011 - Slide 37 - A. Hoy - Advanced disease managementMCO 2011 - Slide 37 - A. Hoy - Advanced disease management
MCO 2011 - Slide 37 - A. Hoy - Advanced disease management
 
ANESTHESIA PREOPERATIVE EVALUATION.pptx
ANESTHESIA PREOPERATIVE EVALUATION.pptxANESTHESIA PREOPERATIVE EVALUATION.pptx
ANESTHESIA PREOPERATIVE EVALUATION.pptx
 
Kawasaki disease
Kawasaki diseaseKawasaki disease
Kawasaki disease
 
Hypertensive crisis in children copy copy.pptx
Hypertensive crisis in children  copy copy.pptxHypertensive crisis in children  copy copy.pptx
Hypertensive crisis in children copy copy.pptx
 
Psych Emergencies
Psych EmergenciesPsych Emergencies
Psych Emergencies
 
Geriatric Population. Geriatric Palliative and End-of-Life Care.
Geriatric Population. Geriatric Palliative and End-of-Life Care.Geriatric Population. Geriatric Palliative and End-of-Life Care.
Geriatric Population. Geriatric Palliative and End-of-Life Care.
 
10. Pulmonary Embolism.pptx
10. Pulmonary Embolism.pptx10. Pulmonary Embolism.pptx
10. Pulmonary Embolism.pptx
 
Major Case Presentation Final Version
Major Case Presentation Final VersionMajor Case Presentation Final Version
Major Case Presentation Final Version
 
A Formal Patient Presentation
A Formal Patient PresentationA Formal Patient Presentation
A Formal Patient Presentation
 
Hyperviscosity syndrome CPC
 Hyperviscosity syndrome CPC Hyperviscosity syndrome CPC
Hyperviscosity syndrome CPC
 
Bronchial embolisation to treat bleeding caused by chronic pulmonary aspergil...
Bronchial embolisation to treat bleeding caused by chronic pulmonary aspergil...Bronchial embolisation to treat bleeding caused by chronic pulmonary aspergil...
Bronchial embolisation to treat bleeding caused by chronic pulmonary aspergil...
 

Hospice_Eligibility_for_Residents

  • 1. HOSPICE ELIGIBILITY AND RECERTIFICATION TERRI HANLON M.D. MEDICAL DIRECTOR CREEKSIDE HOSPICE
  • 2. Objectives  Identify eligible patients early  Knowledge of LCDs  Prognosis prediction  The “new old rules” regarding debility
  • 3. Prognostic Accuracy  Initial certification based on physician or medical director’s best clinical judgment regarding the usual predicted course of the disease  “Individuals who present in the same way generally die in 6 months.”  Several studies have indicated about an 85% accuracy in physician’s 6 month prognosis
  • 4. Eligibility Perspectives  Medicare Language: “ 6 months prognosis or less”  Medicare Reimbursement: “about 5 months”  Physicians: “Are they going to die tonight”  Hospice Nurse: “Do they NEED us?”  Marketer: “I am pretty sure I heard them cough”
  • 5. Eligibility Myths  Eligibility vs. Compassion  Eligibility vs. Care needed or provided  Physician referral vs. other  Cancer = Eligibility
  • 6. Local Coverage Determinations LCD’s  1995, LMRP devised by NHO as “general guidelines”  LCD’s might not be up to date  Different states may have different fiscal intermediaries, so LCD’s may not be uniform  Limited Prognosis is the only real eligibility criterion. Some patients may not meet the criteria but still be appropriate
  • 7. Patient Must Meet 1 of 4 Criteria (to guarantee Medicare payment)  Meets all LCD criteria  Meets most of LCD criteria and has a documented rapid clinical decline  Meets most of LCD criteria and has significant comorbities  A documented provider’s clinical assessment of limited prognosis
  • 8. General Guidelines for all Diagnosis (Nondisease Specific) • Clinical progression of disease • Performance, functional status • Cognition • Nutritional status • Severity of comorbitidites • Burden of symptoms
  • 9. Documenting Clinical Decline  OBTAIN AND REVIEW OLD RECORDS  Get names of all of patients physicians and hospitals  Serial physical findings and diagnostic studies  Multiple recent hospitalizations, ED visits or office visits  Changes in the MDS for nursing facilities  Deterioration while receiving home health services  Failure at rehabilitation
  • 11. Clinical Status  Recurrent or intractable infections such as pneumonia, sepsis or upper urinary tract  Progressive inanition as documented by:  Weight loss and decreasing anthropomorphic measurements not due to *reversible causes such as depression or diuretics  Dysphagia leading to recurrent aspiration and/or inadequate oral intake documented by decreased portions eaten  Progressive stages 3-4 pressure ulcers in spite of optimal treatment
  • 12. Symptoms  Dyspnea, tachypnea  Cough, intractable  Nausea/vomiting poorly responsive to treatment  Diarrhea, intractable  Pain, persistant, requiring increasing doses of medication
  • 13. Signs  Systolic BP <90 or progressive postural hypotension  Ascites  Venous, arterial or lymphatic obstruction  Edema  Pleural/pericardial effusion  Weakness  Changes in level of consciousness
  • 14. Laboratory  Incr. pCO2, decr. pO2, or decr SaO2  Incr. calcium, BUN/Cr or LFTs  Increasing tumor markers (CEA, PSA)  Abnormal electrolytes, Na+ or K+
  • 15. Nutrition  10% weight loss in the elderly over ~6mo  BMI <22kg/m2 (BMI=703x (wt in lbs)/(ht in inches)2  Anthropomorphic measures  Arm, thigh and abdominal girth  Low serum albumin <2.5  Declines enteral or parenteral nutritional support
  • 16. Function  Serial evaluations of ADL’s: bathing, dressing, feeding, transfers, toileting, ambulation  IADL’s  ADL deficits are the most important predictor of 6 mo. Mortality (at least 3/6)  KPS 50%, PPS 40%  Active symptoms
  • 17. Comorbidities  Documenting other significant existing diseases  Document the severity and progression of these diseases  Supporting evidence for 6 mo prognosis:  Additional organ systems involved  Diseases that affect prognosis  Severity more important than the amount of comorbidities
  • 18. Comorbid Conditions  COPD  CHF  CAD  DM  Neurologic disease (CVA, ALS, MS, Parkinson’s)  Dementia  Sepsis  Liver disease  AIDS
  • 19. Is “Debility” a hospice diagnosis?  CMS expects that hospices not use ‘debility’ or ‘adult failure to thrive’ as the primary diagnosis  In those cases that clearly have another diagnosis that can be considered as a principal diagnosis and as many other diagnoses that are related or that contribute to the patient’s terminality be included (up to 17 diagnoses may be submitted).  CMS cites that the Medicare hospice benefit requires the hospice to cover all palliative care related to the terminal illness and all related or contributing illnesses
  • 20. Cancer (simplified)  KPS/PPS may be initially >50%  Aggressive, recurrant or metastatic  Unresponsive to or not a candidate for disease remitting therapy  Patient declines further therapy  Certain cancers have poor prognosis  SCLCA, brain CA, pancreatic cancer, malignant melanoma, stage IV hepatobiliary and gallbladder CA, stage IV renal CA
  • 21. Cancer  Cancers with higher probability of cure  Testicular, ALL, Hodgkin’s  Cancers that may have more favorable extended prognosis with palliative treatment even after metastasis  Prostate, breast, MDS, CML, CLL, multiple myeloma
  • 22. Non-Cancer Disease Specific Criteria  ALS  Cardiac Disease  CAD, CHF, Cardiomyopathy  Pulmonary Disease  COPD, Emphysema, Intersitial lung disease  Liver Disease  Renal Disease  HIV/AIDs  Dementia  Multi-infarct, Lewy Body, NPH  Stroke/Coma  Parkinson’s Disease
  • 23. Pulmonary Disease 1. **Severe chronic lung disease  Disabling dyspnea at rest (unresponsive to bronchodilators)  FEV1 < 30% predicted  Recurrent respiratory infections and or RF  Serial decrease of FEV1>40ml/yr 2. **Hypoxemia at rest on room air, pO2 <55mmHg, pCO2 >50% or O2sat<88%. Patient on chronic O2 3. RHF secondary to Cor pulmonale 4. Unintentional progressive wt loss >10% in last 6 mo 5. Resting tachycardia > 100/min
  • 24. Pulmonary Disease-Assessment  H/o VDRF  pO2/pCO2, 50/50  SaO2 <88% on room air  Elderly  <90% ideal body wt  Continuous O2  Bed-chair existence  Cough and sputum  Hypotension, BP 100/80  Resting tachycardia >100  Tachypnea  Chest wall abnormalities  Use of accessory respiratory muscles  Cyanosis, clubbing  Edema  Wheezing, decr. BrS
  • 25. Heart Disease 1. Patient has had maximal medical management or is not a surgical candidate 2. NYHA IV, significant symptoms at rest---CHF or angina 1. EF <20% or diasytolic disfunction 2. Inability to carry on any physical activity without pain/SOB 3. Supportive factors 1. Resistant symptomatic SVTs or ventricular arrythmias 2. H/o cardiac arrest or resuscitation 3. H/o unexplained syncope 4. Brain embolism of cardiac origin 5. HIV disease
  • 26. Cardiac Assessment  NYHA IV  H/o cardiac arrest  AICD/pacer  H/o syncope  Optimal management with vasodilators or diuretics  Orthopnea and PND  Cachexia, fatique  Continuous oxygen  Hypotension  Tachycardia  “Gallop” S1/S2 + S3, S4  Crackles  Edema  Cyanosis  JVD  Diaphoresis
  • 27. Renal disease: ARF Table 1 *Refusal or withdrawal of dialysis CrCl <10ml/min (<15ml/min for DM), CrCl <15ml/min (<20ml/min for DM) with CHF or Serum CrCl >8 (>6 for DM)  Mechanical ventillation  Malignancy  Chronic lung disease, advanced cardiac disease or liver disease  Sepsis  Immunosuppression/AIDs  Albumin <3.5  Cachexia  Plt <25,000  DIC or GIB
  • 28. Renal Disease: CRF  Table 1 applies  Signs of RF  Oliguria <400ml/hr  Hyperkalemia >7, refractory  Uremic pericarditis  Hepatorenal syndrome  Intractable fluid overload  Cachexia  Age > 75  Symptoms of Uremia  Confusion, obtundation  Intractable N/V  Pruritis  Edema
  • 29. Liver Disease 1. Abnormal labs 1. PT>5 sec over control, INR>1.5 2. Serum albumin <2.5 2. Evidence of ESLD 1. Refractory ascites 2. SBP 3. HRS, oliguria <400ml/day and urine Na+ <10mEq/l 4. Hepatic encephalopathy 5. Recurrent variceal bleeding  Supporting factors  Malnutrition  Muscles wasting, weakness  Alcoholism >80gm EtOH/day  Hepatocellular CA  HBsAg  Hepatitis C refractory to interferon tx
  • 30. Assessment of ESLD  Symptoms  Chg LOC  Sleep disturbance  Depression  Emotional lability  Somnlence  Obtundation  Slurred speech  Oliguria, anuria  Signs  Asterixis  Palmar erythema  Hepatomegaly  Distended abdomen, fluid wave  Edema  Spider hemangioma  Jaundice, scleral icterus  Stupor  coma
  • 31. Neurologic Disease  Dementias  CVA/Coma  ALS/ motor neuron disease
  • 32. Dementia  FAST scale > 7  Unable to ambulate without assistance  Unable to dress without assistance  Unable to bathe without assistance  Urinary and fecal incontinence  No consistently meaningful verbal communication: stereotypical phrases or <6 intelligible words  Patients should have had one of the following in the past 12 mo  Aspiration pneumonia  Pyelonephritis  Septicemia  Decubitus ulcers, multiple stg3- 4  Fever, recurrent after antibx  10% wt loss over 6 mo  Albumin <2.5
  • 33. Acute Stroke and Coma  Has at least one of the following for 3 days:  Coma  PVS  Obtundation/myoclonus  Postanoxic stroke  High risk mortality after 3 days  Abnorm brainstem response  Absent verbal response  Absent withdrawal to pain  Cr >1.5  Supporting factors:  Aspiration pneumonia  Pyelonephritis  Sepsis  Refractory stage 3-4 decubitus ulcers  Recurrant fever after antibiotics
  • 34. Poststroke or Multiinfarct Dementia  Fast >7  One of supporting conditions (last slide) in 3-6 months  Altered nutritional status  Dysphagia  Refusal to eat  Impaired nutritional status despite artificial nutrition  Poor porgnostic Factors:  Nontraumatic hemorrhagic stroke  Lg volume on CT  Ventricular extension  >30% cerebrum  Midline shift>1.5cm  Obstructive hydrocephalus  Thrombo/embolic stroke  Large ant. Infarcts  Large bihemispheric infarcts  Basilar artery occlusion  Bilateral vertebral art. occlusion
  • 35. ALS and other Motor Neuron Disease  Rapid Neurological Progression over 12 mo  Loss of ambulation, speech, chewing  Progressive dependence  Critically Impaired Ventilatory Capacity  VC < 30%  Dyspnea at rest  Refusal of ventillatory support  Critical Nutritional Impairment  Dysphagia or refusal to eat **artificial nutrition or ventillation will significantly alter prognosis
  • 36. ALS and Motor Neuron Disease  Examination by a neurologist within 3 months to confirm diagnosis  Supporting factors  Aspiration pneumonia  Pyelonephritis  Septicemia  Decubitus ulcers, multiple, stages III or IV  Recurrant fever after antibx
  • 37. HIV Disease  CD4 < 25 cell/ mcl (w/o acute illness)  HIV RNA viral load >100,000 persistant or  HIV RNA viral load <100,000 plus:  Refusal of antivirals or prophlactic meds  Declining functional status, KPS < 50  CNS lymphoma  PML  Cryptosporidiosis or toxoplasmosis  AIDs wasting or AIDs dementia  MAC bacteremia  Visceral Kaposi’s sarcoma  Renal failure
  • 38. HIV disease  Supporting Factors:  Chronic persistant diarrhea > 1yr  Alb <2.5  Substance abuse  Age >50  Symptomatic CHF at rest  Advanced liver disease  Age > 50yrs
  • 39. Common Errors  Conclusions without objective evidence  Disease without documented symptoms  Conflicting documentation  Failure to tract S/S over time 6-12 mo  Not providing descriptive narratives
  • 40. Burden of Illness  Age at disease onset, years of illness  Advanced age  Degree of frailty  Location/environment  CG ability  Access to healthcare providers  Secondary conditions and comorbid conditions
  • 41. Scales for Documentation  Function: KPS, PPS, ECOG, ADLs, IADLs, Morse Fall scale  Nutrition: ht, wt, BMI, meal %, cal estimates  Mental Status: Ramsay sedation scale, FAST, MMSE  Cardiac: NYHA, BNP, ECHO  Respiratory: Functional dyspnea scale  Skin: skin turgor, edema, capillary refill, braden scale, pressure ulcer stages  Symptoms: pain scale, PAINAD scale, response to tx
  • 42. Certification  Written or oral certification of terminal illness within 2 days after the beginning of the election period  Must be signed by the hospice physician and the patient’s attending physician  Written certification must be obtained before the claim is sent for payment  If the patient is admitted in the 3rd benefit period or beyond there must be a F2F encounter
  • 43. Ineligibility  Decision of IDG, attending and medical director  Patient must be discharged when ineligibility is determined, not end of cert period  Improvement---sustained, nonmalignant diseases wax and wane  Remember, patients may get better  Admit often occurs after an acute event  Hospice care may improve symptoms
  • 44. Case example #1  Mr. Jones is a 72 y/o male with multiple medical problems including chronic renal disease due to diabetes. His GFR ranges from 18-22%. He has had a fistula put in one year ago but is “holding off on dialysis until his GFR hits 16% as the “bottom limit” to have to do dialysis. He was referred to hospice by his HMO care case manager who states that they have seen a decline in his condition over the last year. He has had two recent hospitalizations. They were both for CHF with severe scrotal edema and dyspnea. He is also a chronic alcoholic, drinking a tall glass of scotch and vermooth every night. On arrival to the ipu he had been without alcohol for nearly two days and appeared completely lucid and conversant. However when he began drinking
  • 45.  Case study (cont) His usual nightly alcohol he became more confused and agitated with repeated falls. His scrotal edema was slow to resolve. The patient lives at home alone. What other information would you like to find out? His he hospice appropriate? What would his hospice diagnosis be? Can he still have dialysis?
  • 46. Case example #2  Yvonne is a 52 y/o female with a mild mental disability due to cerebral palsy. She had multiple hospitalizations over the past 6-12 months for altered mental status and seizures. She was on multidrug therapy for what appeared to be atypical chronic seizures. With these episodes she also had recurrent episodes of aspiration and pneumonia. Before the most recent hospitalization she was able to get around by a wheel chair and was taking care of her elderly mother. She failed a swallow study and did appear to have difficulty swallowing. She was also very depressed because her mother was unable to take care of her at home. She became mostly bedbound after the last hospitalization, dependent on 5/6 ADL’s with KPS 30%.
  • 47.  Case Study (cont.) Is this patient hospice eligible? What further information do you want?